Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2026World Journal of DiabetesOpen Access

Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJavier Donate-CorreaCMCarlos E Martínez-Alberto

Discussion

Loading...

Member takes

Overview

Observational analysis reveals farrerol improves cardiac function in diabetic models, suggesting a new treatment pathway.

Key Points

  • Endothelial protection leads to improved cardiac function and reduced fibrosis in diabetic models.
  • Farrerol downregulates microRNA-29b-3p, restoring sirtuin 1 levels in cardiac endothelial cells and enhancing defenses.
  • Discussion of endothelial cell ferroptosis as a mechanism provides insights into targets for diabetic cardiomyopathy.
  • Promising therapeutic opportunity arises from farrerol's antioxidant and antiferroptotic properties in cardiac treatment.

Cite This Study

Donate-Correa et al. (2026) studied this question.

synapsesocial.com/papers/69a766e7badf0bb9e87dee31https://doi.org/10.4239/wjd.v17.i2.113221
View Full Paper
Ask AI
Bookmark
Share